| Theme | Diagnostic Strategy for Early Stage Pancreatic Cancer | |
|---|---|---|
| Title | Diagnosis of Early Pancreatic Cancer by Biological Markers | |
| Publish Date | 2016/12 | |
| Author | Takashi Kobayashi | Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine |
| Author | Hiromu Kutsumi | Center for Clinical Research and Advanced Medicine, Shiga University of Medical Science |
| Author | Yosuke Yagi | Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine |
| Author | Arata Sakai | Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine |
| Author | Hayato Yoshinaka | Center for Clinical Research and Advanced Medicine, Shiga University of Medical Science |
| Author | Shin Nishiumi | Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine |
| Author | Masaru Yoshida | Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine / Division of Metabolomics Research, Department of Internal Related, Kobe University Graduate School of Medicine |
| Author | Takeshi Azuma | Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine |
| [ Summary ] | Currently, there is no useful biomarker for the diagnosis of pancreatic cancer. Recently, various biomolecules have been investigated for their potential as biomarkers for pancreatic cancer : circulating tumor DNA, micro RNA, exosomes, proteomes, and metabolomes. Although these potential biomarkers need to be further validated, it is expected that accurate biomarkers will be available in the near future, especially for the early detection of pancreatic cancer and distinguishing pancreatic cancer from benign diseases. | |